Skip to main content
profile image
Selected Works of Julia Chapman, MD, FACOG
Article
Phase II trial of oral altretamine for consolidation of clinical complete remission in women with stage III epithelial ovarian cancer: a Southwest Oncology Group trial (SWOG-9326).
Gynecologic Oncology (2001)
  • Mace L. Rothenberg, Vanderbilt University Medical Center
  • P.Y. Liu, Southwest Oncology Group Statistical Center, Seattle, Washington, 98109
  • Sharon Wilczynski, City of Hope National Medical Center
  • Edward V. Hannigan, University of Texas Medical Branch
  • Sheldon A. Weiner, Beaumont Hospital
  • Geoffrey R. Weiss, University of Texas Health Science Center at San Antonio
  • Verda J. Hunter, Kansas City Community Clinical Oncology Program, Kansas City, Missouri, 64131
  • Julia A. Chapman, University of Kansas
  • Amy Tiersten, NewYork–Presbyterian Hospital
  • Peter C. Kohler, Grand Rapids Community Clinical Oncology Program, Grand Rapids, Michigan, 49503
  • David S. Alberts, University of Arizona
Link
Disciplines
Publication Date
August 1, 2001
DOI
10.1006/GYNO.2001.6274
Citation Information
Mace L. Rothenberg, P.Y. Liu, Sharon Wilczynski, Edward V. Hannigan, et al.. "Phase II trial of oral altretamine for consolidation of clinical complete remission in women with stage III epithelial ovarian cancer: a Southwest Oncology Group trial (SWOG-9326)." Gynecologic Oncology Vol. 82 Iss. 2 (2001) p. 317 - 322
Available at: http://works.bepress.com/julia-chapman/13/